Guangzhou Novaken Pharmaceutical
FDA Approved Drugs
Guangzhou Novaken Pharmaceutical
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 4
- Latest Approval Date Jan 28, 2021
- Data Source FDA
- First Approval Date Nov 18, 2020
Company Overview
Social Profiles
Company Snapshot
Guangzhou Novaken Pharmaceutical
Health Industry Incubation Base, 280 East Circle, University Town, Guangzhou 510006
China
en.novaken.cn/ View on MapFDA Approved Drug Records ( 4 records )
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
4 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
4 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ESOMEPRAZOLE MAGNESIUM
Application Number
213859
Product Number
1
Active Ingredient
ESOMEPRAZOLE MAGNESIUM
Dosage Form
-
Strength
EQ 20MG BASE
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.